Reversal of dopamine D2 agonist-induced inhibition of ventral tegmental area neurons by Gq-linked neurotransmitters is dependent on protein kinase C, G protein-coupled receptor kinase, and dynamin

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 1, 2013, Pages 253-263

  Nimitvilai, Sudarat ^a   McElvain, Maureen A ^a   Brodie, Mark S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; BRAIN PROTEIN; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DYNAMIN; DYNASORE; ENZYME INHIBITOR; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; GQ PROTEIN; METHYL 5 [2 (5 NITRO 2 FURYL)VINYL] 2 FUROIC ACID; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTRANSMITTER; PROTEIN KINASE C; QUINPIROLE; SEROTONIN; SEROTONIN RECEPTOR; TETRADECYLTRIMETHYLAMMONIUM BROMIDE; UNCLASSIFIED DRUG;

ADDICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE INHIBITION REVERSAL; DRUG ABUSE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; INTERNALIZATION; INTRACELLULAR SIGNALING; MALE; MOLECULAR MECHANICS; NERVE CELL INHIBITION; NERVE CELL STIMULATION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY; VENTRAL TEGMENTUM;

ANIMALS; CARBAZOLES; DOPAMINE AGONISTS; DYNAMINS; ENZYME INHIBITORS; EXTRACELLULAR SPACE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; MALE; NEURONS; NEUROTRANSMITTER AGENTS; PEPTIDES; PHOSPHORYLATION; PROTEIN KINASE C; QUINPIROLE; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D2; RECEPTORS, NEUROTENSIN; RECEPTORS, SEROTONIN; RECOMBINANT PROTEINS; VENTRAL TEGMENTAL AREA;

EID: 84871685940     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.199844     Document Type: Article

References (63)

1. Bofill-Cardona E, Kudlacek O, Yang Q, Ahorn H, Freissmuth M, and Nanoff C (2000) Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch. J Biol Chem 275:32672-32680.
2. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, and Schwartz JC (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564:203-219.
3. Brodie MS and Dunwiddie TV (1987) Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro. Brain Res 425:106-113. (Pubitemid 17159374)
4. Brodie MS, McElvain MA, Bunney EB, and Appel SB (1999a) Pharmacological reduction of small conductance calcium-activated potassium current (SK) potentiates the excitatory effect of ethanol on ventral tegmental area dopamine neurons. J Pharmacol Exp Ther 290:325-333. (Pubitemid 29302339)
5. Brodie MS, Pesold C, and Appel SB (1999b) Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exp Res 23:1848-1852.
6. Brodie MS, Shefner SA, and Dunwiddie TV (1990) Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res 508:65-69. (Pubitemid 20042066)
7. Bunney BS, Walters JR, Roth RH, and Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560-571.
8. Caillé I, Dumartin B, and Bloch B (1996) Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res 730:17-31. (Pubitemid 26305320)
9. Chieng B, Azriel Y, Mohammadi S, and Christie MJ (2011) Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J Physiol 589:3775-3787.
10. Chuang TT, LeVine H, 3rd, and De Blasi A (1995) Phosphorylation and activation of beta-adrenergic receptor kinase by protein kinase C. J Biol Chem 270:18660-18665.
11. Chuang TT, Paolucci L, and De Blasi A (1996) Inhibition of G protein-coupled receptor kinase subtypes by Ca21/calmodulin. J Biol Chem 271:28691-28696. (Pubitemid 26374698)
12. Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M, Rye DB, Caron MG, Niznik HB, and Levey AI (2000) Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37:125-145. (Pubitemid 30447944)
13. Di Chiara G and Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
14. Diaz J, Lévesque D, Lammers CH, Griffon N, Martres MP, Schwartz JC, and Sokoloff P (1995) Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65:731-745.
15. Diviani D, Lattion AL, Larbi N, Kunapuli P, Pronin A, Benovic JL, and Cotecchia S (1996) Effect of different G protein-coupled receptor kinases on phosphorylation and desensitization of the alpha1B-adrenergic receptor. J Biol Chem 271:5049-5058.
16. Erdtmann-Vourliotis M, Mayer P, Ammon S, Riechert U, and Höllt V (2001) Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Brain Res Mol Brain Res 95:129-137. (Pubitemid 33000371)
17. Gao C and Wolf ME (2008) Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons. J Neurochem 106:2489-2501.
18. Grace AA and Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4 :2866-2876. (Pubitemid 15224431)
19. Gurevich EV and Joyce JN (1999) Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20:60-80. (Pubitemid 29010341)
20. Hausdorff WP, Caron MG, and Lefkowitz RJ (1990) Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 4:2881-2889. (Pubitemid 120012534)
21. Iino M, Furugori T, Mori T, Moriyama S, Fukuzawa A, and Shibano T (2002) Rational design and evaluation of new lead compound structures for selective betaARK1 inhibitors. J Med Chem 45:2150-2159. (Pubitemid 34525795)
22. Ito K, Haga T, Lameh J, and Sadée W (1999) Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260:112-119. (Pubitemid 29095701)
23. Iwata K, Ito K, Fukuzaki A, Inaki K, and Haga T (1999) Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors. Eur J Biochem 263:596-602. (Pubitemid 29337054)
24. Kenakin TP (1987) Analysis of dose-response data, in Pharmacologic Analysis of Drug-Receptor Interaction, pp 129-162, Raven Press, New York.
25. Khan ZU, Gutiérrez A, Martín R, Peñafiel A, Rivera A, and de la Calle A (2000) Dopamine D5 receptors of rat and human brain. Neuroscience 100:689-699.
26. Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27:232-243.
27. Lacey MG, Mercuri NB, and North RA (1987) Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol 392:397-416. (Pubitemid 18014315)
28. Lacey MG, Mercuri NB, and North RA (1989) Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J Neurosci 9:1233-1241. (Pubitemid 19116743)
29. Lammel S, Hetzel A, Häckel O, Jones I, Liss B, and Roeper J (2008) Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57:760-773. (Pubitemid 351335346)
30. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, and Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839-850. (Pubitemid 43779110)
31. Margolis EB, Lock H, Hjelmstad GO, and Fields HL (2006) The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol 577:907-924. (Pubitemid 44873655)
32. Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, and Fields HL (2008) Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. J Neurosci 28:8908-8913.
33. McMahon HT and Boucrot E (2011) Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 12:517-533.
34. Meador-Woodruff JH, Mansour A, Grandy DK, Damask SP, Civelli O, and Watson SJ, Jr (1992) Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci Lett 145:209-212.
35. Mengod G, Villaró MT, Landwehrmeyer GB, Martinez-Mir MI, Niznik HB, Sunahara RK, Seeman P, O'Dowd BF, Probst A, and Palacios JM (1992) Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem Int 20 (Suppl):33S-43S.
36. Mirenowicz J and Schultz W (1996) Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 379:449-451. (Pubitemid 26039524)
37. Mueller AL and Brodie MS (1989) Intracellular recording from putative dopamine-containing neurons in the ventral tegmental area of Tsai in a brain slice preparation. J Neurosci Methods 28:15-22. (Pubitemid 19110207)
38. Namkung Y, Dipace C, Urizar E, Javitch JA, and Sibley DR (2009) G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation. J Biol Chem 284:34103-34115.
39. Namkung Y and Sibley DR (2004) Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J Biol Chem 279:49533-49541. (Pubitemid 39625841)
40. Neve KA, Seamans JK, and Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165-205. (Pubitemid 39332216)
41. Nimitvilai S, Arora DS, and Brodie MS (2012a) Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C. Neuropsychopharmacology 37:543-556.
42. Nimitvilai S, Arora DS, and Brodie MS (2012b) Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C. Neuropsychopharmacology 37:543-556.
43. Nimitvilai S and Brodie MS (2010) Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area. J Pharmacol Exp Ther 333:555-563.
44. Nimitvilai S, McElvain MA, Arora DS, and Brodie MS (2012c) Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q). J Neurophysiol 108:263-274.
45. Oades RD and Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434:117-165. (Pubitemid 17064083)
46. Palacios JM and Kuhar MJ (1981) Neurotensin receptors are located on dopamine-containing neurones in rat midbrain. Nature 294:587-589. (Pubitemid 12164588)
47. Pesavento E, Margotti E, Righi M, Cattaneo A, and Domenici L (2000) Blocking the NGF-TrkA interaction rescues the developmental loss of LTP in the rat visual cortex: role of the cholinergic system. Neuron 25:165-175. (Pubitemid 30316519)
48. Pitcher JA, Freedman NJ, and Lefkowitz RJ (1998) G protein-coupled receptor kinases. Annu Rev Biochem 67:653-692. (Pubitemid 28411141)
49. Premont RT, Inglese J, and Lefkowitz RJ (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 9:175-182.
50. Pronin AN and Benovic JL (1997) Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C. J Biol Chem 272:3806-3812. (Pubitemid 27066891)
51. Pronin AN, Satpaev DK, Slepak VZ, and Benovic JL (1997) Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J Biol Chem 272:18273-18280. (Pubitemid 27306417)
52. Quan A, McGeachie AB, and Keating DJ, et al. (2007) Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II. Mol Pharmacol 72:1425-1439. (Pubitemid 350146080)
53. Quirion R, Chiueh CC, Everist HD, and Pert A (1985) Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Res 327:385-389. (Pubitemid 15167337)
54. Rivera A, Peñafiel A, MegíasM, Agnati LF, López-Téllez JF, Gago B, Gutiérrez A, de la Calle A, and Fuxe K (2008) Cellular localization and distribution of dopamine D(4) receptors in the rat cerebral cortex and their relationship with the cortical dopaminergic and noradrenergic nerve terminal networks. Neuroscience 155:997-1010.
55. Rockman HA, Choi DJ, Rahman NU, Akhter SA, Lefkowitz RJ, and Koch WJ (1996) Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci USA 93:9954-9959. (Pubitemid 26296716)
56. Rogue P, Zwiller J, Malviya AN, and Vincendon G (1990) Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors. Biochem Int 22:575-582.
57. Sesack SR, Aoki C, and Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106.
58. Sibley DR, Monsma FJ, Jr, and Shen Y (1993) Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 35:391-415.
59. Sterne-Marr R and Benovic JL (1995) Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam Horm 51:193-234.
60. Sun X, Milovanovic M, Zhao Y, and Wolf ME (2008) Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocultured with prefrontal cortex neurons. J Neurosci 28:4216-4230.
61. Thibault D, Albert PR, Pineyro G, and Trudeau LÉ (2011) Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism. J Biol Chem 286:9174-9184.
62. Winstel R, Freund S, Krasel C, Hoppe E, and Lohse MJ (1996) Protein kinase crosstalk: membrane targeting of the beta-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci USA 93:2105-2109. (Pubitemid 26079888)
63. Wise RA (1996) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251.